This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saharinen, P.
Right arrow Articles by Silvennoinen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saharinen, P.
Right arrow Articles by Silvennoinen, O.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2000, p. 3387-3395, Vol. 20, No. 10
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain

Pipsa Saharinen,1 Kati Takaluoma,2 and Olli Silvennoinen1,2,3,*

Department of Virology, Haartman Institute, FIN-00014 University of Helsinki,1 and Institute of Medical Technology, University of Tampere,2 and Department of Clinical Microbiology, Tampere University Hospital,3 FIN-33101 Tampere, Finland

Received 11 October 1999/Returned for modification 7 December 1999/Accepted 14 February 2000

Activation of Jak tyrosine kinases through hematopoietic cytokine receptors occurs as a consequence of ligand-induced aggregation of receptor-associated Jaks and their subsequent autophosphorylation. Jak kinases consist of a C-terminal tyrosine kinase domain, a pseudokinase domain of unknown function, and Jak homology (JH) domains 3 to 7, implicated in receptor-Jak interaction. We analyzed the functional roles of the different protein domains in activation of Jak2. Deletion analysis of Jak2 showed that the pseudokinase domain but not JH domains 3 to 7 negatively regulated the catalytic activity of Jak2 as well as Jak2-mediated activation of Stat5. Phosphorylation of Stat5 by wild-type Jak2 was dependent on the SH2 domain of Stat5; however, this requirement was lost upon deletion of the pseudokinase domain of Jak2. Investigation of the mechanisms of the pseudokinase domain-mediated inhibition of Jak2 suggested that this regulation did not involve protein tyrosine phosphatases. Instead, analysis of interactions between the tyrosine kinase domain and Jak2 suggested that the pseudokinase domain interacted with the kinase domain. Furthermore, coexpression of the pseudokinase domain inhibited the activity of the single tyrosine kinase domain. Finally, deletion of the pseudokinase domain of Jak2 deregulated signal transduction through the gamma interferon receptor by significantly increasing ligand-independent activation of Stat transcription factors. These results indicate that the pseudokinase domain negatively regulates the activity of Jak2, probably through an interaction with the kinase domain, and this regulation is required to keep Jak2 inactive in the absence of ligand stimulation. Furthermore, the pseudokinase domain may have a role in regulation of Jak2-substrate interactions.

* Corresponding author. Mailing address: Department of Virology, Haartman Institute, Haartmaninkatu 3, P.O. Box 21, FIN-00014 University of Helsinki, Finland. Phone: 358-9-191 26484. Fax: 358-9-191 26491. E-mail: ltolsi{at}uta.fi.

Molecular and Cellular Biology, May 2000, p. 3387-3395, Vol. 20, No. 10
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Kubo, T., Kuroda, Y., Shimizu, H., Kokubu, A., Okada, N., Hosoda, F., Arai, Y., Nakamura, Y., Taniguchi, H., Yanagihara, K., Imoto, I., Inazawa, J., Hirohashi, S., Shibata, T. (2009). Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer. Carcinogenesis 30: 1857-1864 [Abstract] [Full Text]  
  • Zhao, L., Dong, H., Zhang, C. C., Kinch, L., Osawa, M., Iacovino, M., Grishin, N. V., Kyba, M., Huang, L. J.-s. (2009). A JAK2 Interdomain Linker Relays Epo Receptor Engagement Signals to Kinase Activation. J. Biol. Chem. 284: 26988-26998 [Abstract] [Full Text]  
  • Kawashima, T., Bao, Y. C., Minoshima, Y., Nomura, Y., Hatori, T., Hori, T., Fukagawa, T., Fukada, T., Takahashi, N., Nosaka, T., Inoue, M., Sato, T., Kukimoto-Niino, M., Shirouzu, M., Yokoyama, S., Kitamura, T. (2009). A Rac GTPase-Activating Protein, MgcRacGAP, Is a Nuclear Localizing Signal-Containing Nuclear Chaperone in the Activation of STAT Transcription Factors. Mol. Cell. Biol. 29: 1796-1813 [Abstract] [Full Text]  
  • Hornakova, T., Staerk, J., Royer, Y., Flex, E., Tartaglia, M., Constantinescu, S. N., Knoops, L., Renauld, J.-C. (2009). Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor {alpha} Homodimers. J. Biol. Chem. 284: 6773-6781 [Abstract] [Full Text]  
  • Haan, C., Kroy, D. C., Wuller, S., Sommer, U., Nocker, T., Rolvering, C., Behrmann, I., Heinrich, P. C., Haan, S. (2009). An Unusual Insertion in Jak2 Is Crucial for Kinase Activity and Differentially Affects Cytokine Responses. J. Immunol. 182: 2969-2977 [Abstract] [Full Text]  
  • Lu, X., Huang, L. J.-S., Lodish, H. F. (2008). Dimerization by a Cytokine Receptor Is Necessary for Constitutive Activation of JAK2V617F. J. Biol. Chem. 283: 5258-5266 [Abstract] [Full Text]  
  • Haan, S., Margue, C., Engrand, A., Rolvering, C., Schmitz-Van de Leur, H., Heinrich, P. C., Behrmann, I., Haan, C. (2008). Dual Role of the Jak1 FERM and Kinase Domains in Cytokine Receptor Binding and in Stimulation-Dependent Jak Activation. J. Immunol. 180: 998-1007 [Abstract] [Full Text]  
  • Bao, L., Tessier, C., Prigent-Tessier, A., Li, F., Buzzio, O. L., Callegari, E. A., Horseman, N. D., Gibori, G. (2007). Decidual Prolactin Silences the Expression of Genes Detrimental to Pregnancy. Endocrinology 148: 2326-2334 [Abstract] [Full Text]  
  • Kawashima, T., Bao, Y. C., Nomura, Y., Moon, Y., Tonozuka, Y., Minoshima, Y., Hatori, T., Tsuchiya, A., Kiyono, M., Nosaka, T., Nakajima, H., Williams, D. A., Kitamura, T. (2006). Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. JCB 175: 937-946 [Abstract] [Full Text]  
  • Campbell, P. J., Green, A. R. (2006). The Myeloproliferative Disorders. NEJM 355: 2452-2466 [Full Text]  
  • Waxman, D. J., O'Connor, C. (2006). Growth Hormone Regulation of Sex-Dependent Liver Gene Expression. Mol. Endocrinol. 20: 2613-2629 [Abstract] [Full Text]  
  • Kurzer, J. H., Saharinen, P., Silvennoinen, O., Carter-Su, C. (2006). Binding of SH2-B Family Members within a Potential Negative Regulatory Region Maintains JAK2 in an Active State.. Mol. Cell. Biol. 26: 6381-6394 [Abstract] [Full Text]  
  • Mazurkiewicz-Munoz, A. M., Argetsinger, L. S., Kouadio, J.-L. K., Stensballe, A., Jensen, O. N., Cline, J. M., Carter-Su, C. (2006). Phosphorylation of JAK2 at Serine 523: a Negative Regulator of JAK2 That Is Stimulated by Growth Hormone and Epidermal Growth Factor.. Mol. Cell. Biol. 26: 4052-4062 [Abstract] [Full Text]  
  • Nirmala, J., Brueggeman, R., Maier, C., Clay, C., Rostoks, N., Kannangara, C. G., von Wettstein, D., Steffenson, B. J., Kleinhofs, A. (2006). Subcellular localization and functions of the barley stem rust resistance receptor-like serine/threonine-specific protein kinase Rpg1. Proc. Natl. Acad. Sci. USA 103: 7518-7523 [Abstract] [Full Text]  
  • Bock, O., Busche, G., Koop, C., Schroter, S., Buhr, T., Kreipe, H. (2006). Detection of the Single Hotspot Mutation in the JH2 Pseudokinase Domain of Janus Kinase 2 in Bone Marrow Trephine Biopsies Derived from Chronic Myeloproliferative Disorders. J. Mol. Diagn. 8: 170-177 [Abstract] [Full Text]  
  • Lu, X., Gross, A. W., Lodish, H. F. (2006). Active Conformation of the Erythropoietin Receptor: RANDOM AND CYSTEINE-SCANNING MUTAGENESIS OF THE EXTRACELLULAR JUXTAMEMBRANE AND TRANSMEMBRANE DOMAINS. J. Biol. Chem. 281: 7002-7011 [Abstract] [Full Text]  
  • Levine, R. L., Wernig, G. (2006). Role of JAK-STAT Signaling in the Pathogenesis of Myeloproliferative Disorders. ASH Education Book 2006: 233-239 [Abstract] [Full Text]  
  • Lucet, I. S., Fantino, E., Styles, M., Bamert, R., Patel, O., Broughton, S. E., Walter, M., Burns, C. J., Treutlein, H., Wilks, A. F., Rossjohn, J. (2006). The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor. Blood 107: 176-183 [Abstract] [Full Text]  
  • Lu, X., Levine, R., Tong, W., Wernig, G., Pikman, Y., Zarnegar, S., Gilliland, D. G., Lodish, H. (2005). Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. Proc. Natl. Acad. Sci. USA 102: 18962-18967 [Abstract] [Full Text]  
  • Staerk, J., Kallin, A., Demoulin, J.-B., Vainchenker, W., Constantinescu, S. N. (2005). JAK1 and Tyk2 Activation by the Homologous Polycythemia Vera JAK2 V617F Mutation: CROSS-TALK WITH IGF1 RECEPTOR. J. Biol. Chem. 280: 41893-41899 [Abstract] [Full Text]  
  • He, K., Loesch, K., Cowan, J. W., Li, X., Deng, L., Wang, X., Jiang, J., Frank, S. J. (2005). Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor. Endocrinology 146: 4755-4765 [Abstract] [Full Text]  
  • Sommer, U., Schmid, C., Sobota, R. M., Lehmann, U., Stevenson, N. J., Johnston, J. A., Schaper, F., Heinrich, P. C., Haan, S. (2005). Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation: CONTRIBUTIONS OF Src- AND RECEPTOR-TYROSINE KINASES. J. Biol. Chem. 280: 31478-31488 [Abstract] [Full Text]  
  • Pesu, M., O'Shea, J., Hennighausen, L., Silvennoinen, O. (2005). Identification of an Acquired Mutation in Jak2 Provides Molecular Insights into the Pathogenesis of Myeloproliferative Disorders. Mol. Interv. 5: 211-215 [Abstract] [Full Text]  
  • Boggon, T. J., Li, Y., Manley, P. W., Eck, M. J. (2005). Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog. Blood 106: 996-1002 [Abstract] [Full Text]  
  • Radtke, S., Haan, S., Jorissen, A., Hermanns, H. M., Diefenbach, S., Smyczek, T., Schmitz-VandeLeur, H., Heinrich, P. C., Behrmann, I., Haan, C. (2005). The Jak1 SH2 Domain Does Not Fulfill a Classical SH2 Function in Jak/STAT Signaling but Plays a Structural Role for Receptor Interaction and Up-regulation of Receptor Surface Expression. J. Biol. Chem. 280: 25760-25768 [Abstract] [Full Text]  
  • Tefferi, A., Gilliland, D. G. (2005). The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis. Mayo Clin Proc. 80: 947-958 [Abstract]  
  • Vainchenker, W., Constantinescu, S. N. (2005). A Unique Activating Mutation in JAK2 (V617F) Is at the Origin of Polycythemia Vera and Allows a New Classification of Myeloproliferative Diseases. ASH Education Book 2005: 195-200 [Abstract] [Full Text]  
  • Behrmann, I., Smyczek, T., Heinrich, P. C., Schmitz-Van de Leur, H., Komyod, W., Giese, B., Muller-Newen, G., Haan, S., Haan, C. (2004). Janus Kinase (Jak) Subcellular Localization Revisited: THE EXCLUSIVE MEMBRANE LOCALIZATION OF ENDOGENOUS JANUS KINASE 1 BY CYTOKINE RECEPTOR INTERACTION UNCOVERS THE Jak{middle dot}RECEPTOR COMPLEX TO BE EQUIVALENT TO A RECEPTOR TYROSINE KINASE. J. Biol. Chem. 279: 35486-35493 [Abstract] [Full Text]  
  • Argetsinger, L. S., Kouadio, J.-L. K., Steen, H., Stensballe, A., Jensen, O. N., Carter-Su, C. (2004). Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its Activity. Mol. Cell. Biol. 24: 4955-4967 [Abstract] [Full Text]  
  • Hofmann, S. R., Lam, A. Q., Frank, S., Zhou, Y.-J., Ramos, H. L., Kanno, Y., Agnello, D., Youle, R. J., O'Shea, J. J. (2004). Jak3-Independent Trafficking of the Common {gamma} Chain Receptor Subunit: Chaperone Function of Jaks Revisited. Mol. Cell. Biol. 24: 5039-5049 [Abstract] [Full Text]  
  • Kurzer, J. H., Argetsinger, L. S., Zhou, Y.-J., Kouadio, J.-L. K., O'Shea, J. J., Carter-Su, C. (2004). Tyrosine 813 Is a Site of JAK2 Autophosphorylation Critical for Activation of JAK2 by SH2-B{beta}. Mol. Cell. Biol. 24: 4557-4570 [Abstract] [Full Text]  
  • Roberts, J. L., Lengi, A., Brown, S. M., Chen, M., Zhou, Y.-J., O'Shea, J. J., Buckley, R. H. (2004). Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation. Blood 103: 2009-2018 [Abstract] [Full Text]  
  • He, K., Wang, X., Jiang, J., Guan, R., Bernstein, K. E., Sayeski, P. P., Frank, S. J. (2003). Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and Signaling. Mol. Endocrinol. 17: 2211-2227 [Abstract] [Full Text]  
  • Shaw, M. H., Boyartchuk, V., Wong, S., Karaghiosoff, M., Ragimbeau, J., Pellegrini, S., Muller, M., Dietrich, W. F., Yap, G. S. (2003). A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc. Natl. Acad. Sci. USA 100: 11594-11599 [Abstract] [Full Text]  
  • Saharinen, P., Vihinen, M., Silvennoinen, O. (2003). Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase Domain. Mol. Biol. Cell 14: 1448-1459 [Abstract] [Full Text]  
  • Ravandi, F., Talpaz, M., Estrov, Z. (2003). Modulation of Cellular Signaling Pathways: Prospects for Targeted Therapy in Hematological Malignancies. Clin. Cancer Res. 9: 535-550 [Abstract] [Full Text]  
  • Le, M. N., Kohanski, R. A., Wang, L.-H., Sadowski, H. B. (2002). Dual Mechanism of Signal Transducer and Activator of Transcription 5 Activation by the Insulin Receptor. Mol. Endocrinol. 16: 2764-2779 [Abstract] [Full Text]  
  • Saharinen, P., Silvennoinen, O. (2002). The Pseudokinase Domain Is Required for Suppression of Basal Activity of Jak2 and Jak3 Tyrosine Kinases and for Cytokine-inducible Activation of Signal Transduction. J. Biol. Chem. 277: 47954-47963 [Abstract] [Full Text]  
  • Zhu, T., Ling, L., Lobie, P. E. (2002). Identification of a JAK2-independent Pathway Regulating Growth Hormone (GH)-stimulated p44/42 Mitogen-activated Protein Kinase Activity. GH ACTIVATION OF Ral AND PHOSPHOLIPASE D IS Src-DEPENDENT. J. Biol. Chem. 277: 45592-45603 [Abstract] [Full Text]  
  • Ungureanu, D., Saharinen, P., Junttila, I., Hilton, D. J., Silvennoinen, O. (2002). Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1. Mol. Cell. Biol. 22: 3316-3326 [Abstract] [Full Text]  
  • O'Brien, K. B., O'Shea, J. J., Carter-Su, C. (2002). SH2-B Family Members Differentially Regulate JAK Family Tyrosine Kinases. J. Biol. Chem. 277: 8673-8681 [Abstract] [Full Text]  
  • Frasor, J., Barkai, U., Zhong, L., Fazleabas, A. T., Gibori, G. (2001). PRL-Induced ER{alpha} Gene Expression Is Mediated by Janus Kinase 2 (Jak2) While Signal Transducer and Activator of Transcription 5b (Stat5b) Phosphorylation Involves Jak2 and a Second Tyrosine Kinase. Mol. Endocrinol. 15: 1941-1952 [Abstract] [Full Text]  
  • Lindauer, K., Loerting, T., Liedl, K. R., Kroemer, R. T. (2001). Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation. Protein Eng Des Sel 14: 27-37 [Abstract] [Full Text]  
  • O'Shea, J. J, Visconti, R., Cheng, T. P, Gadina, M. (2000). Jaks and Stats as therapeutic targets. Ann Rheum Dis 59: i115-118 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»